4
Changes in Ownership
Edgewise Therapeutics, Inc. Filed Acc 0001562180-21-006455
Chief Scientific Officer sold 1,270 shares at $18.02 ($22,885)
From the SEC's structured data for this filing
Trades in this filing
Russell Alan J · Chief Scientific Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-10-11 | Sale : show line 1 in the form | −1,270 | $18.02 | $22,885 | 151,024 | D |
| Open-market sales · 1,270 sh · avg $18.02 · $22,885 | ||||||
Loading xslF345X03/primarydocument.xml…